P3 Health Partners Inc. (PIII) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    P3 Health Partners Inc.

    NASDAQ: PIII · Real-Time Price · USD
    9.20
    -0.99 (-9.70%)
    At close: Sep 26, 2025, 3:59 PM

    P3 Health Partners Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.5B 1.27B 1.05B 491.06B
    Cost of Revenue
    		 1.56B 1.23B 1.14B 668.07M
    Gross Profit
    		 -144.97M 31.64M -95.01M 490.4B
    Operating Income
    		 -320.66M -167.86M -1.56B -31.41B
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -305.99M -183.73M -1.56B -31.41B
    Net Income
    		 -135.85M -57.77M -270.13M -10.08M
    Selling & General & Admin
    		 113.93M 125.59M 162.4M 54.89B
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 147.81M 73.97M 1.13B 464.76B
    Operating Expenses
    		 261.74M 199.56M 1.3B 519.65B
    Interest Expense
    		 22.17M 15.98M 11.4M 10.68M
    Selling & Marketing Expenses
    		 1.33M 3.23M 5.1M 1.5B
    Cost & Expenses
    		 1.82B 1.43B 1.3B 519.65B
    Income Tax Expense
    		 4.39M 2.69M 1.9M -31.4B
    Shares Outstanding (Basic)
    		 2.9M 1.9M 831.58K 831.58K
    Shares Outstanding (Diluted)
    		 2.94M 1.9M 831.58K 831.58K
    EPS (Basic)
    		 -46.79 -30.44 -324.84 -188.17
    EPS (Diluted)
    		 -54.06 -30.44 -324.84 -188.17
    EBITDA
    		 -197.76M -81.07M -1.46B -184.61M
    EBIT
    		 -283.82M -167.75M -1.55B -193.34M
    Depreciation & Amortization
    		 86.06M 86.67M 87.29M 8.72M

    Add to Watchlist